The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
SOHO Italy 2020 | Finding novel targets for myelofibrosis from animal models
Anna Rita Migliaccio, PhD, University of Bologna, Bologna, Italy, discusses studies on GATA1 low mice that have been used to develop novel targets in the treatment of primary myelofibrosis. Specifically discussed are the role of inflammatory cytokines and integrins in the development of myelofibrosis as well as potential targets for treatment. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
